Biotech · Private company
JW Pharmaceutical
Track this companyFree. Adds JW Pharmaceutical to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- CWP232291Phase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- LEO 152020 tabletPhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- LEO 152020 TabletPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Phase 1a: CWP232291Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Phase 1b: CWP232291, Lenalidomide, DexamethasonePhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic DermatitisPHASE2 · COMPLETED · started Dec 13, 2021ClinicalTrials.gov NCT05117060 · fetched Nov 12, 2026
- A Trial to Evaluate the Effect of Food on LEO 152020PHASE1 · COMPLETED · started Jan 9, 2020ClinicalTrials.gov NCT04203836 · fetched Nov 12, 2026
- Clinical Study of CWP232291 in Acute Myeloid Leukemia PatientsPHASE1_PHASE2 · TERMINATED · started Feb 6, 2017ClinicalTrials.gov NCT03055286 · fetched Nov 12, 2026
- Clinical Study of CWP232291 in Relapsed or Refractory Myeloma PatientsPHASE1 · COMPLETED · started Oct 19, 2015ClinicalTrials.gov NCT02426723 · fetched Nov 12, 2026